Navigation Links
Paul D. Duke Resigns From Mesa's Board of Directors
Date:7/8/2010

LAKEWOOD, Colo., July 8 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB) today announced that Paul D. Duke, citing health reasons, has resigned as a member of the Company's Board of Directors, effectively immediately.

"Paul's experience and insight have been extremely helpful to me and the whole management team at Mesa," said John J. Sullivan, President and CEO.  "Paul managed Mesa's Medical product line from its infancy until 2002 when he retired from the Company as an active employee.  Mesa's position as a key quality control supplier to the worldwide dialysis industry is largely due to the effort that Paul put into building the Medical product line and Mesa's brand in the marketplace.  I would like to thank Paul for his many years of service, not only to Mesa, but to the whole dialysis industry."

"Paul has been a key part of Mesa's success since cofounding the company with me in 1982," said Luke R. Schmieder, Chairman.  "Paul was a trusted colleague and friend who helped build Mesa into the company it is today.  Though he leaves as a member of our Board, Paul will always have a special place in the history of Mesa."

Mesa Laboratories develops, acquires, manufactures and markets electronic instruments and disposables for industrial, pharmaceutical and medical applications.

This news release contains forward-looking statements which involve risks and uncertainties.  The Company's actual results could differ materially from those in any such forward-looking statements.  Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company's Annual Report on Form-10K for the year ended March 31, 2010 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.


'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. InteRNA Technologies Announces Establishment of Scientific Advisory Board
2. Mitchell J. Blutt, M.D. Appointed to Questcor Board of Directors
3. NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
4. Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors
5. Accuray Appoints Peter Fine to Board of Directors
6. K-V Pharmaceutical Company Announces the Nomination and Appointment of New Independent Member to the Board of Directors
7. HealthWarehouse.com Receives VIPPS Accreditation From The National Association of Boards of Pharmacy
8. DUSA Pharmaceuticals Announces Slate of Nominees for Election to the Board of Directors
9. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend and Announces Election of New Officer
10. Axelars Board Strengthened
11. Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)...  Las Vegas ophthalmology practice, Center For Sight, announced ... Dublin ), an implant that shunts ... intraocular pressure in patients with moderate to severe glaucoma. ... glaucoma that can lead to progressive optic nerve damage ... untreated. According to the National Eye Institute, ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
(Date:3/28/2017)... , March 28, 2017  "US Cancer Generics ... the various indicators and trend analysis related to ... in mainstream pharmaceutical market in US. The report ... the growth on cancer generics drugs in recent ... saving of billions of dollars for various stake ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... and services, is proud to announce it has joined the National Association for ... the interests of chronically ill, disabled, and dying Americans of all ages and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, ... the launch of a free, public-facing tool for analyzing the costs of various ... to provide comparative information to patients, providers, insurers and pharmaceutical companies about the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a ... Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip ... in association with efforts by the American College of Surgeons, U.S. Department of ...
(Date:3/28/2017)... ... 28, 2017 , ... Usually, the impending arrival of warmer weather means the ... about a double chin, this means more anxiety than elation. The cosmetic dermatology experts ... people, a double chin is undesirable,” Dr. Goldman said, “but it seems doubly so ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, ... ensuring high-quality results and maintaining GMP and USP compliance. In a new webinar ... with GMP requirements " these requirements are explained. The challenge is to ...
Breaking Medicine News(10 mins):